Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (TSE:MRMD)
:MRMD
MRMD Stock Chart & Stats
C$0.10
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.10
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.48
Previous CloseN/A
Volume0.00
Average Volume (3M)46.35K
Market Cap
C$47.40M
Enterprise ValueC$133.02M
Total Cash (Recent Filing)C$6.60M
Total Debt (Recent Filing)C$107.96M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Mar 11, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding395,073,640
10 Day Avg. Volume89,801
30 Day Avg. Volume46,354
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.71
Price to Sales (P/S)0.28
P/FCF Ratio-7.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.34Price Target Upside241.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Revenue MixA near-even split between wholesale and retail revenue reduces single-channel exposure and supports more stable top-line performance. Growing wholesale (11% YoY) leverages MariMed’s production capabilities and proprietary brands to scale distribution without proportional retail capex.
Multi-state Footprint & Brand PositionOperating across multiple states (IL, MA, DE and others) and holding leading share in Delaware provides regulatory diversification and local market leadership. This footprint supports durable market access, cross-state brand rollouts, and resilience to single-state regulatory volatility.
Improving Cash Generation And Cost ControlMaterial improvement in operating cash flow (from $0.3M to $2.7M) alongside lower operating expenses and a positive cash balance indicates better cash conversion and discipline. That strengthens the company’s ability to fund operations and invest without immediate external financing.
Bears Say
High LeverageA debt-to-equity ratio above 1.4 limits financial flexibility and increases vulnerability to higher interest costs. For a company with negative profits, persistent leverage raises refinancing and covenant risks and constrains capital allocation for growth or weathering industry cycles.
Negative Margins And Recurring LossesSustained negative margins and recurring quarterly net losses erode shareholder equity and limit internal reinvestment. Until margins stabilize and profitability returns, the firm will likely need ongoing capital or cost restructuring, hindering long-term scale and investor confidence.
Retail Softness And Market ExitsWeak retail trends, margin compression (400 bps QoQ gross margin decline) and a market exit signal challenges in retail competitiveness and state-level economics. These structural retail pressures can limit earnings leverage from store expansion and complicate scale economics.
MariMed News
MRMD FAQ
What was MariMed Inc’s price range in the past 12 months?
MariMed Inc lowest stock price was C$0.06 and its highest was C$0.48 in the past 12 months.
What is MariMed Inc’s market cap?
MariMed Inc’s market cap is C$47.40M.
When is MariMed Inc’s upcoming earnings report date?
MariMed Inc’s upcoming earnings report date is Mar 11, 2026 which is in 16 days.
How were MariMed Inc’s earnings last quarter?
MariMed Inc released its earnings results on Nov 05, 2025. The company reported -C$0.014 earnings per share for the quarter, the consensus estimate of -C$0.014 by C$0.
Is MariMed Inc overvalued?
According to Wall Street analysts MariMed Inc’s price is currently Undervalued.
Does MariMed Inc pay dividends?
MariMed Inc does not currently pay dividends.
What is MariMed Inc’s EPS estimate?
MariMed Inc’s EPS estimate is -0.01.
How many shares outstanding does MariMed Inc have?
MariMed Inc has 395,073,640 shares outstanding.
What happened to MariMed Inc’s price movement after its last earnings report?
MariMed Inc reported an EPS of -C$0.014 in its last earnings report, expectations of -C$0.014. Following the earnings report the stock price went down -12.5%.
Which hedge fund is a major shareholder of MariMed Inc?
Currently, no hedge funds are holding shares in TSE:MRMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MariMed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.34 (241.29% Upside)
C$0.34 (241.29% Upside)
Insider Transactions
Bought Shares
Worth $4.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.40%
12-Months-Change
Fundamentals
Return on Equity
-28.43%
Trailing 12-Months
Asset Growth
-3.33%
Trailing 12-Months
Company Description
MariMed Inc
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
MRMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative aspects. MariMed reported sequential growth in revenue and positive cash flow, driven by strong performance in Delaware and strategic expansion into the hemp market. However, challenges in retail revenue, increased net losses, and exit from the Missouri market indicate ongoing industry pressures.View all TSE:MRMD earnings summariesMRMD Stock 12 Month Forecast
Average Price Target
C$0.34
▲(241.29% Upside)
Technical Analysis
Options Prices
Currently, No data available
---